Report Detail
Global Pentazocine Market Insights, Forecast to 2025
- RnM3772722 |
- 23 September, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain. It is believed to work by activating (agonizing) κ-opioid receptors (KOR) and blocking (antagonizing) μ-opioid receptors (MOR). As such it is called an opioid as it delivers its effects on pain by interacting with the opioid receptors. It shares many of the side effects of other opioids like constipation, nausea, itching, drowsiness and a reduced effort to breathe, but unlike most other opioids it fairly frequently causes hallucinations, nightmares and delusions. It is also, unlike most other opioids, subject to a ceiling effect, which is when at a certain dose (which differs from person-to-person) no more pain relief, or side effects, is obtained by increasing the dose any further.
The global Pentazocine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pentazocine market based on company, product type, end user and key regions.
This report studies the global market size of Pentazocine in key regions like North America, Europe, China and Japan, focuses on the consumption of Pentazocine in these regions.
This research report categorizes the global Pentazocine market by top players/brands, region, type and end user. This report also studies the global Pentazocine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
pfizer
Merck KGaA
LUPIN PHARMACEUTICALS
...
Pentazocine market size by Type
Injections
Tablets
Pentazocine market size by Applications
Adults
Children
Elderly
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pentazocine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pentazocine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pentazocine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pentazocine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pentazocine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pentazocine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pentazocine Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pentazocine Market Size Growth Rate by Type
- 1.4.2 Injections
- 1.4.3 Tablets
- 1.5 Market by Application
- 1.5.1 Global Pentazocine Market Size Growth Rate by Application
- 1.5.2 Adults
- 1.5.3 Children
- 1.5.4 Elderly
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pentazocine Market Size
- 2.1.1 Global Pentazocine Revenue 2014-2025
- 2.1.2 Global Pentazocine Sales 2014-2025
- 2.2 Pentazocine Growth Rate by Regions
- 2.2.1 Global Pentazocine Sales by Regions
- 2.2.2 Global Pentazocine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pentazocine Sales by Manufacturers
- 3.1.1 Pentazocine Sales by Manufacturers
- 3.1.2 Pentazocine Sales Market Share by Manufacturers
- 3.2 Pentazocine Revenue by Manufacturers
- 3.2.1 Pentazocine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pentazocine Revenue Share by Manufacturers (2014-2019)
- 3.3 Pentazocine Price by Manufacturers
- 3.4 Pentazocine Manufacturing Base Distribution, Product Types
- 3.4.1 Pentazocine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pentazocine Product Type
- 3.4.3 Date of International Manufacturers Enter into Pentazocine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Pentazocine Sales by Type
- 4.2 Global Pentazocine Revenue by Type
- 4.3 Pentazocine Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Pentazocine Breakdown Data by Application
6 North America
- 6.1 North America Pentazocine by Country
- 6.1.1 North America Pentazocine Sales by Country
- 6.1.2 North America Pentazocine Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pentazocine by Type
- 6.3 North America Pentazocine by Application
7 Europe
- 7.1 Europe Pentazocine by Country
- 7.1.1 Europe Pentazocine Sales by Country
- 7.1.2 Europe Pentazocine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pentazocine by Type
- 7.3 Europe Pentazocine by Application
8 Asia Pacific
- 8.1 Asia Pacific Pentazocine by Region
- 8.1.1 Asia Pacific Pentazocine Sales by Region
- 8.1.2 Asia Pacific Pentazocine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Pentazocine by Type
- 8.3 Asia Pacific Pentazocine by Application
9 Central & South America
- 9.1 Central & South America Pentazocine by Country
- 9.1.1 Central & South America Pentazocine Sales by Country
- 9.1.2 Central & South America Pentazocine Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Pentazocine by Type
- 9.3 Central & South America Pentazocine by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Pentazocine by Country
- 10.1.1 Middle East and Africa Pentazocine Sales by Country
- 10.1.2 Middle East and Africa Pentazocine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pentazocine by Type
- 10.3 Middle East and Africa Pentazocine by Application
11 Company Profiles
- 11.1 Teva
- 11.1.1 Teva Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Teva Pentazocine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Teva Pentazocine Products Offered
- 11.1.5 Teva Recent Development
- 11.2 pfizer
- 11.2.1 pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 pfizer Pentazocine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 pfizer Pentazocine Products Offered
- 11.2.5 pfizer Recent Development
- 11.3 Merck KGaA
- 11.3.1 Merck KGaA Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck KGaA Pentazocine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck KGaA Pentazocine Products Offered
- 11.3.5 Merck KGaA Recent Development
- 11.4 LUPIN PHARMACEUTICALS
- 11.4.1 LUPIN PHARMACEUTICALS Company Details
- 11.4.2 Company Business Overview
- 11.4.3 LUPIN PHARMACEUTICALS Pentazocine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 LUPIN PHARMACEUTICALS Pentazocine Products Offered
- 11.4.5 LUPIN PHARMACEUTICALS Recent Development
12 Future Forecast
- 12.1 Pentazocine Market Forecast by Regions
- 12.1.1 Global Pentazocine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pentazocine Revenue Forecast by Regions 2019-2025
- 12.2 Pentazocine Market Forecast by Type
- 12.2.1 Global Pentazocine Sales Forecast by Type 2019-2025
- 12.2.2 Global Pentazocine Revenue Forecast by Type 2019-2025
- 12.3 Pentazocine Market Forecast by Application
- 12.4 North America Pentazocine Forecast
- 12.5 Europe Pentazocine Forecast
- 12.6 Asia Pacific Pentazocine Forecast
- 12.7 Central & South America Pentazocine Forecast
- 12.8 Middle East and Africa Pentazocine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pentazocine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pentazocine. Industry analysis & Market Report on Pentazocine is a syndicated market report, published as Global Pentazocine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pentazocine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
